Statins in the prevention of prostate cancer recurrence: are certain biases exaggerating the results?

J Clin Oncol. 2010 Nov 1;28(31):e644; author reply e645-6. doi: 10.1200/JCO.2010.31.1720. Epub 2010 Sep 27.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Body Mass Index
  • Confounding Factors, Epidemiologic
  • Disease-Free Survival
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Hyperlipidemias / drug therapy
  • Male
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / prevention & control*
  • Obesity / complications*
  • Obesity / mortality
  • Observer Variation
  • Predictive Value of Tests
  • Prognosis
  • Prostatic Neoplasms / complications
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / prevention & control*
  • Prostatic Neoplasms / radiotherapy
  • Research Design
  • Smoking / adverse effects*
  • Smoking / mortality

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors